Effect of Loading of Midazolam or Dexmedetomidine on Hemodynamics

• Status: Withdrawn
• Trial end date: 2018-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Loading dose of dexmedetomidine is related hemodynamic instability such as bradycardia and hypertension.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Konkuk University Medical Center
• Treatments: Dexmedetomidine; Midazolam

Criteria

Inclusion Criteria:

• patients who were planned to undergo knee arthroscopy under spinal anesthesia

Exclusion Criteria:

• age < 20 years

• underlying heart, liver or kidney disease

• hypersensitivity to midazolam or dexmedetomidine